Diagnostics-World
Twitter   LinkedIn Facebookinstagram RSS  
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • Post a Press Release
    • View Press Releases
    • Submit a Story
    • Reprint Articles
  • Advertise
    • Media Kit
    • Digital Advertising Opportunities
    • Lead Generation
    • Whitepapers
    • Webinars
    • Podcasts
    • Editorial Calender
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside Ebooks
  • Events
    • Webinars
    • Industry Events
    • Dx Conferences
    • Tri-Conference
    • Next Generation Dx
    • Dx Innovation Summit
  • About
    • Editorial Profile
    • Editorial Calender
    • Contact
  • Molecular Med Tri-Conference
 
  • Worldwide Diagnostic Companies Granted Emergency Use Authorization From FDA For SARS-CoV-2 Tests

    Diagnostics World News | Forty-one molecular diagnostics tests and eight serology tests for SARS-CoV-2 virus infection have been granted Emergency Use Authorization from the Food and Drug Administration.

    Apr 27, 2020
  • Diagnostics Community Continues Consorted Efforts To Address COVID-19

    Diagnostics World News | As COVID-19 continues impacting individuals and communities on a global scale, the diagnostics community is working around the clock to provide both relief and solutions. Their latest efforts include 3D-printed swabs, biosensors that detect COVID-19 in less than one minute, and much more.

    Apr 24, 2020
  • The Coronavirus Pandemic Demonstrates Why We Need To Go Beyond Testing

    Diagnostics World News | As the coronavirus pandemic continues, world governments and health agencies are rushing to buy large quantities of laboratory and portable rapid testing kits. But imagine integrating real-time disease mapping with the right diagnostic test.

    Apr 23, 2020
  • MicroGenDX Offers COVID-19 Saliva Test; More Than 20,000 Samples Tested

    Diagnostics World News | MicroGenDX announced it has validated a real-time COVID-19 test using sputum samples, which the company’s CEO says carries a much larger viral load than the typical nasal swab.

    Apr 22, 2020
  • Mayo Clinic, Beaumont Health, And More: Diagnostics Community Continues Fight Against COVID-19

    Diagnostics World News | The diagnostics community continues to aggressively research and innovate for SARS-CoV-2 solutions. The latest this week includes research on saliva-based detection, CRISPR diagnostics, serological testing, and much more.

    Apr 17, 2020
  • World’s First Ultrasound Biosensor Designed To Fit Clinical Realities

    Diagnostics World News | Researchers at Monash University in Melbourne, Australia have developed the world's first ultrasound biosensor that can be inserted deep into the tissues to measure diagnostic markers in real time.

    Apr 14, 2020
  • BBI Solutions, Bardy Diagnostics, Mount Sinai, And More: Diagnostics Community Rallies Against COVID-19

    Diagnostics World News | The SARS-CoV-2 virus is serving as a rallying cry across the diagnostics landscape inspiring creative new solutions, partnerships, and ideas to address the outbreak, treat and prevent the disease it causes, and address the life adjustments of our new normal.

    Apr 10, 2020
  • Three Types Of COVID-19 Tests Needed For Return To Normalcy

    Diagnostics World News | Three types of COVID-19 tests—symptomatic molecular testing, asymptomatic screening and next generation sequencing—are critical to bringing a semblance of normalcy to the lives of employed Americans that includes a safe return to the workplace, according to a framework newly drafted by the Policy and Reimbursement Working Group of BloodPAC.

    Apr 9, 2020
  • PoC Diagnostics Innovation: Overcoming The Sample Prep Challenge

    Diagnostics World News Contributed Commentary | Point of care testing offers many benefits, from faster patient turnaround for improved clinical outcomes and streamlining healthcare for cost efficiency, to better “patient as customer” experiences. However, the shift from a lab with specialist staff to the physician’s office, drive through test centers, or the hospital bedside presents various challenges.

    Apr 8, 2020
  • «
  • 121
  • 122
  • 123
  • 124
  • 125 (current)
  • 126
  • 127
  • 128
  • 129
  • 130
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy